Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies is a research paper published in Journal for ImmunoTherapy of Cancer (2022). On theSindex it has a DataRank of 0.917. It has been cited 19 times, with 19 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.449
From this paper's citation signal
Citation Network Contribution
0.468
From 17 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 19 citers.
NIH
Grant: 5K12CA139160-09
Developing an Oncology Workforce for the 21st Century - Renewal 01
NCATS/NIH
Grant: T32 CA009566
NCATS/NIH
Grant: UL1TR000430
National Cancer Institute
Grant: P30CA014599
NCI NIH HHS
Grant: K12 CA139160
NIAID NIH HHS
Grant: T32 AI007090
National Institutes of Health
Grant: 2UL1TR000430-06
Re-Engineering Translational Research at the University of Chicago
National Institutes of Health
Grant: 3P30CA014599-36S1
Cancer Center Support Grant
National Institutes of Health
Grant: 5T32CA009566-19
Basic Medical Research Training in Medical Oncology
FWCI
1.68
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals